Published October, 2011
By P.H. Cox
Publisher: Springer
Series: Developments in Nuclear Medicine
Rating:
Availability: Available

Next the text follows the usual pattern of discussion on the pharmacodynamics of radiopharmaceuticals, followed by a description of various clinical disease patterns of the liver and the use of cholescintigraphy in evaluating these diseases.

---

Published October, 2011
By Frank Deconinck and Axel Bossuyt
Publisher: Springer
Series: Developments in Nuclear Medicine
Rating:
Availability: Available

---

Published October, 2011
By M.R. Hardeman, Y. Najean and Max Hardeman
Publisher: Springer
Series: Developments in Nuclear Medicine
Rating:
Availability: Available

---

Published October, 2011
By Frank Deconinck and M.H. Jonckheer
Publisher: Springer
Series: Developments in Nuclear Medicine
Rating:
Availability: Available

---

Published October, 2011
By M.R. Hardeman, C. Kessler, H. Henningsen, J. Petrovici and Max Hardeman
Publisher: Springer
Series: Developments in Nuclear Medicine
Rating:
Availability: Available

AIMS OF THE COLOGNE-SYMPOSIUM ON RADIOLABELLED PLATELETS In 1976, M. Because of its physical characteristics (2.8 days half-life, 94% gamma emission) 111 Indium turned out to be the best isotope for platelet kinetic studies as well as for the measurement of platelet incorporation by Thrombi to be used up until now.

---

Published September, 2011
By Giovanni Lucignani and R. Bares
Publisher: Springer
Series: Developments in Nuclear Medicine
Rating:
Availability: Available

During the past decade Positron Emission Tomography (PET) has turned from a highly sophisticated tool developed for basic research in neurology and cardiology into an advanced nuclear medicine imaging technique ready for routine use.

---

Published September, 2011
By Steven J. Mather
Publisher: Springer
Series: Developments in Nuclear Medicine
Rating:
Availability: Available

However, a major new direction of interest now lies in the development of receptor-binding radio-tracers which can be used to perform in-vivo characterisation of diseased tissues and it is likely that much of the future research in this field will follow this direction.

---

Published September, 2011
By R.M. Lambrecht
Publisher: Springer
Series: Developments in Nuclear Medicine
Rating:
Availability: Available

Radiophannaceuticals labeled with short-lived radionuclides are utilized to unravel biochemical processes, and to diagnosis and treat diseases of the living body are-developed through extensive evaluation in ~iological models.

---

Published December, 2010
By Hans-Jurgen Machulla and H.J. Machulla
Publisher: Springer
Series: Developments in Nuclear Medicine
Rating:
Availability: Available

Although the clinical importance of hypoxia imaging is obviously great, to date neither the clinical nor the scientific community at an international level has focused many research activities on the hypoxia problem.

---

Published December, 2010
By David W. Townsend, Bernard Bendriem, B. Bendriem and D.W. Townsend
Publisher: Springer
Series: Developments in Nuclear Medicine
Rating: 1.00
Availability: Available

The application of 3D methodology has recently been receiving increasing attention at many PET centres, and this monograph is an attempt to provide a state-of-the-art review of this methodology, covering 3D reconstruction methods, quantitative procedures, current tomography performance, and clinical and research applications.

---